Cargando…

Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes

OBJECTIVE: Macronutrient “preloads” can reduce postprandial glycemia by slowing gastric emptying and stimulating glucagon-like peptide-1 (GLP-1) secretion. An ideal preload would entail minimal additional energy intake and might be optimized by concurrent inhibition of dipeptidyl peptidase-4 (DPP-4)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tongzhi, Bound, Michelle J., Zhao, Beiyi R., Standfield, Scott D., Bellon, Max, Jones, Karen L., Horowitz, Michael, Rayner, Christopher K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687261/
https://www.ncbi.nlm.nih.gov/pubmed/23359361
http://dx.doi.org/10.2337/dc12-2294
_version_ 1782273890617131008
author Wu, Tongzhi
Bound, Michelle J.
Zhao, Beiyi R.
Standfield, Scott D.
Bellon, Max
Jones, Karen L.
Horowitz, Michael
Rayner, Christopher K.
author_facet Wu, Tongzhi
Bound, Michelle J.
Zhao, Beiyi R.
Standfield, Scott D.
Bellon, Max
Jones, Karen L.
Horowitz, Michael
Rayner, Christopher K.
author_sort Wu, Tongzhi
collection PubMed
description OBJECTIVE: Macronutrient “preloads” can reduce postprandial glycemia by slowing gastric emptying and stimulating glucagon-like peptide-1 (GLP-1) secretion. An ideal preload would entail minimal additional energy intake and might be optimized by concurrent inhibition of dipeptidyl peptidase-4 (DPP-4). We evaluated the effects of a low-energy d-xylose preload, with or without sitagliptin, on gastric emptying, plasma intact GLP-1 concentrations, and postprandial glycemia in type 2 diabetes. RESEARCH DESIGN AND METHODS: Twelve type 2 diabetic patients were studied on four occasions each. After 100 mg sitagliptin (S) or placebo (P) and an overnight fast, patients consumed a preload drink containing either 50 g d-xylose (X) or 80 mg sucralose (control [C]), followed after 40 min by a mashed potato meal labeled with (13)C-octanoate. Blood was sampled at intervals. Gastric emptying was determined. RESULTS: Both peak blood glucose and the amplitude of glycemic excursion were lower after PX and SC than PC (P < 0.01 for each) and were lowest after SX (P < 0.05 for each), while overall blood glucose was lower after SX than PC (P < 0.05). The postprandial insulin-to-glucose ratio was attenuated (P < 0.05) and gastric emptying was slower (P < 0.01) after d-xylose, without any effect of sitagliptin. Plasma GLP-1 concentrations were higher after d-xylose than control only before the meal (P < 0.05) but were sustained postprandially when combined with sitagliptin (P < 0.05). CONCLUSIONS: In type 2 diabetes, acute administration of a d-xylose preload reduces postprandial glycemia and enhances the effect of a DPP-4 inhibitor.
format Online
Article
Text
id pubmed-3687261
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36872612014-07-01 Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes Wu, Tongzhi Bound, Michelle J. Zhao, Beiyi R. Standfield, Scott D. Bellon, Max Jones, Karen L. Horowitz, Michael Rayner, Christopher K. Diabetes Care Original Research OBJECTIVE: Macronutrient “preloads” can reduce postprandial glycemia by slowing gastric emptying and stimulating glucagon-like peptide-1 (GLP-1) secretion. An ideal preload would entail minimal additional energy intake and might be optimized by concurrent inhibition of dipeptidyl peptidase-4 (DPP-4). We evaluated the effects of a low-energy d-xylose preload, with or without sitagliptin, on gastric emptying, plasma intact GLP-1 concentrations, and postprandial glycemia in type 2 diabetes. RESEARCH DESIGN AND METHODS: Twelve type 2 diabetic patients were studied on four occasions each. After 100 mg sitagliptin (S) or placebo (P) and an overnight fast, patients consumed a preload drink containing either 50 g d-xylose (X) or 80 mg sucralose (control [C]), followed after 40 min by a mashed potato meal labeled with (13)C-octanoate. Blood was sampled at intervals. Gastric emptying was determined. RESULTS: Both peak blood glucose and the amplitude of glycemic excursion were lower after PX and SC than PC (P < 0.01 for each) and were lowest after SX (P < 0.05 for each), while overall blood glucose was lower after SX than PC (P < 0.05). The postprandial insulin-to-glucose ratio was attenuated (P < 0.05) and gastric emptying was slower (P < 0.01) after d-xylose, without any effect of sitagliptin. Plasma GLP-1 concentrations were higher after d-xylose than control only before the meal (P < 0.05) but were sustained postprandially when combined with sitagliptin (P < 0.05). CONCLUSIONS: In type 2 diabetes, acute administration of a d-xylose preload reduces postprandial glycemia and enhances the effect of a DPP-4 inhibitor. American Diabetes Association 2013-07 2013-06-12 /pmc/articles/PMC3687261/ /pubmed/23359361 http://dx.doi.org/10.2337/dc12-2294 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Wu, Tongzhi
Bound, Michelle J.
Zhao, Beiyi R.
Standfield, Scott D.
Bellon, Max
Jones, Karen L.
Horowitz, Michael
Rayner, Christopher K.
Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes
title Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes
title_full Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes
title_fullStr Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes
title_full_unstemmed Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes
title_short Effects of a d-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes
title_sort effects of a d-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687261/
https://www.ncbi.nlm.nih.gov/pubmed/23359361
http://dx.doi.org/10.2337/dc12-2294
work_keys_str_mv AT wutongzhi effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes
AT boundmichellej effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes
AT zhaobeiyir effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes
AT standfieldscottd effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes
AT bellonmax effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes
AT joneskarenl effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes
AT horowitzmichael effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes
AT raynerchristopherk effectsofadxylosepreloadwithorwithoutsitagliptinongastricemptyingglucagonlikepeptide1andpostprandialglycemiaintype2diabetes